

DOVELabs

DOVE
Saving lives one injection at a time
The DOVE device is an auto-injector that can detect an overdose as it occurs and inject naloxone in a timely manner to reverse the fatal overdose.It will be capable of preventing the overdose deaths that occur when patients are alone. This will also help save insurers and governments from hospitalization costs of overdoses where naloxone is not administered in time.
DOVE was originally developed in the Brenner Bioengineering Lab, and is now part of an academic collaboration including Penn and Drexel University. Our goal is to develop DOVE and other technologies to address the intersection of medicine and social justice.
Naloxone is an effective overdose antidote if a bystander administers it
>81,000
US Opioid Overdose Deaths
Jun 2019 - June 2020
>52%
Fatal Overdoses Occur Alone
Meet The Team

Jake Brenner
MD, PhD

Anush Lingamoorthy
Ph.D. Student, Drexel Electrical Engineering

David Gordon
Medical Student, Thomas Jefferson University

Julia Gasior
Medical Student, University of Pennsylvania

Katie Kanter
Medical Student, University of Pennsylvania

Khang Lam
Master student, Drexel BioMedical Engineering

Ethan Donlon
Master Student, UPenn Mechanical Engineering

Emma Ma
Research Specialist, University of Pennsylvania

Ayan Mandal
Medical Student, University of Pennsylvania

Korey Henderson
Medical Student, University of Pennsylvania

Sope Eweje
Medical Student, University of Pennsylvania

Alex Lee
Medical Student, University of Pennsylvania